Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury.

[1]  B. Kasiske,et al.  Oxidative modification of low-density lipoproteins by mesangial cells. , 1993, Journal of the American Society of Nephrology : JASN.

[2]  D. Schlondorff.  Cellular mechanisms of lipid injury in the glomerulus. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  H. van Goor,et al.  Renal apolipoproteins in nephrotic rats. , 1993, The American journal of pathology.

[4]  U. Steinbrecher,et al.  Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. , 1993, Kidney international.

[5]  B. Kasiske,et al.  Hypertension, hyperlipidemia, and renal damage. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  T. Liberek,et al.  Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. , 1993, Journal of the American Society of Nephrology : JASN.

[7]  B. Rovin,et al.  LDL stimulates mesangial fibronectin production and chemoattractant expression. , 1993, Kidney international.

[8]  Z. Varghese,et al.  Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  D. Wheeler,et al.  Interactions between lipoproteins, glomerular cells and matrix. , 1993, Mineral and electrolyte metabolism.

[10]  H. Abboud,et al.  Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. , 1992, The American journal of physiology.

[11]  G. Remuzzi,et al.  Thromboxane synthesis and action within the kidney. , 1992, Kidney international.

[12]  G. Chisolm.  Cytotoxicity of oxidized lipoproteins , 1991 .

[13]  V. Fidler,et al.  Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[14]  J. Neugarten,et al.  Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. , 1991, Kidney international.

[15]  S. Shah,et al.  Oxidant mechanisms in glomerulonephritis. , 1991, Seminars in nephrology.

[16]  D. Steinberg,et al.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[17]  D. Steinberg,et al.  Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. , 1991, Journal of lipid research.

[18]  Z. Varghese,et al.  Characterisation of the binding of low-density lipoproteins to cultured rat mesangial cells. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  G. Chisolm,et al.  Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. , 1991, Journal of lipid research.

[20]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[21]  H. Aynedjian,et al.  Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol. , 1990, The Journal of clinical investigation.

[22]  R. Mason,et al.  Human glomerular epithelial cell proteoglycans. , 1990, Archives of biochemistry and biophysics.

[23]  Z. Varghese,et al.  Effects of low-density lipoproteins on mesangial cell growth and viability in vitro. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  D. Lovett,et al.  Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. , 1989, Kidney international.

[25]  Z. Varghese,et al.  Glomerular structures and lipids in progressive renal disease. , 1989, The American journal of medicine.

[26]  J. Wasserman,et al.  Interactions of low density lipoprotein with rat mesangial cells. , 1989, Kidney international.

[27]  D. Steinberg,et al.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Karnovsky,et al.  Focal and segmental glomerulosclerosis: analogies to atherosclerosis. , 1988, Kidney international.

[29]  J. Frohlich,et al.  Glomerular disease in hypercholesterolemic guinea pigs: a pathogenetic study. , 1988, Kidney international.

[30]  横出 正之.  Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein , 1988 .

[31]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[32]  D. Schlondorff.  The glomerular mesangial cell: an expanding role for a specialized pericyte , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  D. Morel,et al.  Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle , 1987, Journal of cellular physiology.

[34]  D. Steinberg,et al.  Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.

[36]  A. Chait,et al.  Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. , 1986, The Journal of clinical investigation.

[37]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[38]  A. Scanu,et al.  Precautionary measures for collecting blood destined for lipoprotein isolation. , 1986, Methods in enzymology.

[39]  D. Morel,et al.  Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.

[40]  A. Tall,et al.  Stimulation of Vascular Smooth Muscle Cell Prostacyclin and Prostaglandin E2 Synthesis by Plasma High and Low Density Lipoproteins , 1984, Circulation research.

[41]  A. Sevanian,et al.  The influence of phospholipase A2 and glutathione peroxidase on the elimination of membrane lipid peroxides. , 1983, Archives of biochemistry and biophysics.

[42]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[43]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[44]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[45]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.